Annual Report for Financial Year 2023-24 filed with BSE

Results View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.0%Reaction day

₹7.52

prior close

₹7.67

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.3%+2.3% vs market

Commodity Chemicals peers, median of 55sector-0.1%+2.1% vs sector

On the reaction day the stock moved 2.3 pts more than Nifty Microcap 250 and 2.1 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.0-0.3+2.3-0.1+2.1

Next day

+4.0+0.8+3.2-0.6+4.6

+6.0+0.9+5.1-0.5+6.5

+8.0+1.8+6.2-0.1+8.1

+10.1+1.5+8.7+0.0+10.1

+12.2+1.7+10.6-0.1+12.3

+16.4-1.1+17.4-1.3+17.7

15d

+28.1+1.0+27.0+0.2+27.9

+11.6+0.4+11.2+0.6+11.0

-26.9+6.4-33.2+1.1-28.0

-50.0+5.5-55.5+3.4-53.4

UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 55Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Kobo Biotech Ltd has submitted its Annual Report for the financial year 2023-24 to BSE. This is a routine regulatory filing that gives shareholders access to the full-year audited financial statements, directors report, and auditor observations. Detailed financials, ratios and notes are available in the attached PDF on the BSE portal.

Likely market impact

No immediate price impact expected. Investors should review full-year financials and auditor remarks for any material concerns.